Kolon TissueGene, Inc. (KOSDAQ:950160)

South Korea · Delayed Price · Currency is KRW

15,320

+80 (0.52%)

Sep 22, 2026, 3:30 PM KST

Kolon TissueGene Financials Overview

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	4,797	5,159	5,073	3,706	9,456	4,003
Revenue Growth	-12.58%	1.68%	36.90%	-60.81%	136.22%	12.58%
Gross Profit	556.91	614.5	545.13	365.92	7,645	392.15
Operating Income	-24,033	-22,323	-21,998	-20,511	-16,308	-47,101
Net Income	-180,968	-192,587	-33,799	-17,224	-11,136	-47,370
Earnings Per Share	-2163.19	-2343.80	-439.20	-240.20	-168.00	-773.60
EPS Growth	-	-	-	-	-	-

Revenue by Segment

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Complex Distribution	3,710	1,905	4,006	3,555	2,871
Bio	-	7,552	-	-	76.51

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	95,315	82,091	802.87	27,433	58,263	39,013
Total Debt	62,750	79,561	17,240	6,476	7,074	7,233
Net Cash (Debt)	32,566	2,530	-16,437	20,957	51,189	31,781
Net Cash Growth	-	-	-	-59.06%	61.07%	-22.18%
Net Cash Per Share	389.28	30.79	-213.60	292.25	772.24	519.01

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	-17,375	-24,014	-20,452	-24,109	-26,776	-40,020
Capital Expenditures	-701.6	-1,196	-129.26	-260.58	-68.52	-548.04
Free Cash Flow	-18,077	-25,210	-20,581	-24,370	-26,844	-40,568
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	11.61%	11.91%	10.75%	9.87%	80.85%	9.80%
Operating Margin	-501.03%	-432.73%	-433.58%	-553.45%	-172.46%	-1176.59%
Pretax Margin	-3772.84%	-3732.85%	-668.07%	-457.93%	-103.86%	-1177.86%
Profit Margin	-3772.84%	-3733.25%	-666.19%	-464.76%	-117.77%	-1183.31%
FCF Margin	-376.87%	-488.69%	-405.66%	-657.56%	-283.88%	-1013.40%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 22, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PS Ratio	269.97	1284.12	364.17	176.95	64.77	129.55